March/ April 2005

Clinical trials, not finding new chemical entities, are the most costly aspect of drug development. Peter Rees looks at the software solutions that might make clinical trials cheaper and faster

Providing scientific software is not just a matter of development, but makes strategic sense, Felix Grant believes

Clinical trials, not finding new chemical entities, are the most costly aspect of drug development. Peter Rees looks at the software solutions that might make clinical trials cheaper and faster

John Murphy profiles a leading statistician of our DNA

Ray Girvan reports on sonification - the representation of data as sound. Well-established in applications for the visually impaired, it has far wider scientific possibilities